M'lissAHudsonMD

PubMed

• 10 citations
  A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis.
  Jessie Gills, Ravan Moret, Xin Zhang, John Nelson, Grace Maresh, Linh Hellmers, Daniel Canter, M'Liss A. Hudson, Shams Halat, Marc R. Matrana, Michael P. Marino, Jakob...> ;Oncotarget. 2018 Aug 24
• Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical: Trial of 6,6...
  Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC> ;J. Urol.. 2016-12-21
• 18 citations
  Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines☆
  Bernd J. Schmitz-Dräger, Eva C. Kuckuck, Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Amanda F. Saltzman, Abhishek Kumar Srivastava, M'Liss A. Hudson, Roland Seiler, T...> ;Urologic Oncology. 2016 Oct 1
• 13 citations
  Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation
  Amanda F. Saltzman, Suhong Luo, Jeffery F. Scherrer, Kenneth D. Carson, Robert L. Grubb, M´Liss A. Hudson> ;Urologic Oncology. 2015 Jul 1
• 112 citations
  Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus.
  Bernd J. Schmitz-Dräger, Michael J. Droller, Vinata B. Lokeshwar, Yair Lotan, M'Liss A. Hudson, Bas W.G. van Rhijn, Michael Marberger, Yves Fradet, George P. Hemstreet...> ;Urologia Internationalis. 2015 Feb 24
• 16 citations
  Assessing the quality of studies on the diagnostic accuracy of tumor markers
  Peter J. Goebell, Ashish M. Kamat, Richard Sylvester, Peter McL. Black, Michael J. Droller, Guilherme Godoy, M'Liss A. Hudson, Kerstin Junker, Wassim Kassouf, Margaret...> ;Urologic Oncology. 2014 Oct 1
• 11 citations
  Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans
  M'Liss A. Hudson, Suhong Luo, Timothy Chrusciel, Yan Yan, Robert L. Grubb, Kenneth R. Carson, Jeffrey F. Scherrer> ;Urologic Oncology. 2014 Jan 1
• 43 citations
  Comparison of 2004 and 1973 world health organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with ...
  Dengfeng Cao, Robin T. Vollmer, Jason Luly, Samay Jain, Timur M. Roytman, Charles W. Ferris, M'Liss A. Hudson> ;Urology. 2010 Sep 1
• 14 citations
  Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy.
  Ted A. Skolarus, Eugene W. Lee, Katherine S. Virgo, Matthew D. Katz, M'Liss A. Hudson, Adam S. Kibel, Robert L. Grubb> ;Journal of the American College of Surgeons. 2009 Aug 1
• 7 citations
  Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
  M'Liss A. Hudson, L M McReynold> ;Advances in Experimental Medicine and Biology. 1999 Jan 1
• 2 citations
  The place of radiotherapy for localized invasive bladder cancer
  Hirohiko Tsujii, M.K Gospodarowicz, M Bolla, K Fujita, M'Liss A. Hudson, N Mitsuhashi, JT Roberts, J Shimazaki> ;Urologic Oncology. 1998 Jul 1
• 68 citations
  Invasion of the bladder by transitional cell carcinoma: Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and...
  Robin T. Vollmer, Peter A. Humphrey, Paul E. Swanson, Mark R. Wick, M'Liss A. Hudson> ;Cancer. 1998 Feb 15
• 32 citations
  Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guerin
  Michael F. Sarosdy, Michael J. Manyak, Arthur I. Sagalowsky, Arie S. Belldegrun, Mitchell C. Benson, William Bihrle, Peter R. Carroll, William J. Ellis, M'Liss A. Huds...> ;Urology. 1998 Feb 1
• 21 citations
  URINARY INTERLEUKIN-8/CREATININE LEVEL AS A PREDICTOR OF RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY IN BLADDER TUMOR PATIENTS
  Richard Rabinowitz, Deborah S. Smith, Debra Tiemann, M'Liss A. Hudson> ;The Journal of Urology. 1997 Nov 1
• 145 citations
  Improved detection of recurrent bladder cancer using the bard BTA stat test
  Michael F. Sarosdy, M'Liss A. Hudson, William J. Ellis, M.S. Soloway, R.W. deVere White, Joel Sheinfeld, M.V. Jarowenko, P.F. Schellhammer, E.W. Schervish, Jinal Patel...> ;Urology. 1998 Feb 1
• 46 citations
  Urokinase and the Urokinase Receptor: Association With In Vitro Invasiveness of Human Bladder Cancer Cell Lines
  M'Liss A. Hudson, L M McReynolds> ;Journal of the National Cancer Institute. 1997 May 21
• 53 citations
  Effect of Canarypox Virus (ALVAC)-Mediated Cytokine Expression on Murine Prostate Tumor Growth
  M. Kawakita, Ganesh S. Rao, Julie Ritchey, David K. Ornstein, M'Liss A. Hudson, James Tartaglia, E. Paoletti, Peter A. Humphrey, T. J. Harmon, Timothy L. Ratliff> ;Journal of the National Cancer Institute. 1997 Mar 19
• 4 citations
  Editorial: A New Staging System for Transitional Cell Carcinoma Involvement of the Prostate and Reconfirmation Studies of Intravesical Therapy for Superficial Bladder ...
  M'Liss A. Hudson> ;The Journal of Urology. 1996 Sep 1
• 135 citations
  Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies
  David G. Bostwick, Thomas M. Wheeler, Michael L. Blute, David M. Barrett, Gregory T. MacLennan, Thomas J. Sebo, Peter T. Scardino, Peter A. Humphrey, M'Liss A. Hudson,...> ;Urology. 1996 Jul 1
• 13 citations
  Bropirimine immunotherapy of upper urinary tract carcinoma in situ.
  Michael F. Sarosdy, Louis L. Pisters, Peter R. Carroll, Mitchell C. Benson, Timothy D. Moon, Donald L. Lamm, M'Liss A. Hudson, Seth P. Lerner, Michael O. Koch, Paul F....> ;Urology. 1996 Jul 1
• BCG treatment: Current status
  Timothy L. Ratliff, M'Liss A. Hudson> ;Acta Urologica Belgica. 1996 Jan 1
• 11 citations
  Derivation and application of upper limits for prostate specific antigen in men aged 50–74 years with no clinical evidence of prostatic carcinoma
  Bruce L. Dalkin, Frederick R. Ahmann, J.B. Kopp, William J. Catalona, Timothy L. Ratliff, M'Liss A. Hudson, Jerome P. Richie, Peter T. Scardino, Robert C. Flanigan, Je...> ;British Journal of Urology. 1995 Sep 1
• Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.
  Sarosdy MF, deVere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF, Jarowenko MV, Adams G, Blumenstein BA> ;J. Urol.. 1995-08-01
• 7 citations
  Failure of intravesical interferon-alfa-2b for the treatment of patients with superficial bladder cancer previously failing intravesical BCG Therapy.
  M'Liss A. Hudson, Timothy L. Ratliff> ;Urologic Oncology. 1995 May 1
• 216 citations
  Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves
  William J. Catalona, M'liss A. Hudson, Peter T. Scardino, Jerome P. Richie, Frederick R. Ahmann, Robert C. Flanigan, Jean B. deKernion, Timothy L. Ratliff, Louis R. Ka...> ;The Journal of Urology. 1994 Dec 1
• Join now to see all